Literature DB >> 22829012

Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas.

K J Johnson1, M J Fisher, R L Listernick, K N North, E K Schorry, D Viskochil, M Weinstein, J B Rubin, D H Gutmann.   

Abstract

Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant cancer syndromes worldwide. Individuals with NF1 have a wide variety of clinical features including a strongly increased risk for pediatric brain tumors. The etiology of pediatric brain tumor development in NF1 is largely unknown. Recent studies have highlighted the contribution of parent-of-origin effects to tumorigenesis in sporadic cancers and cancer predisposition syndromes; however, there is limited data on this effect for cancers arising in NF1. To increase our understanding of brain tumor development in NF1, we conducted a multi-center retrospective chart review of 240 individuals with familial NF1 who were diagnosed with a pediatric brain tumor (optic pathway glioma; OPG) to determine whether a parent-of-origin effect exists overall or by the patient's sex. Overall, 50 % of individuals with familial NF1 and an OPG inherited the NF1 gene from their mother. Similarly, by sex, both males and females were as likely to inherit the NF1 gene from their mother as from their father, with 52 % and 48 % of females and males with OPGs inheriting the NF1 gene from their mother. In conclusion, in contrast to findings from other studies of sporadic cancers and cancer predisposition syndromes, our results indicate no parent-of-origin effect overall or by patient sex for OPGs in NF1.

Entities:  

Mesh:

Year:  2012        PMID: 22829012      PMCID: PMC3693850          DOI: 10.1007/s10689-012-9549-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  14 in total

1.  Segregation analysis of peripheral neurofibromatosis (NF1).

Authors:  M Littler; N E Morton
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

2.  Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes.

Authors:  Christine M van Vliet; James G Dowty; Jane L van Vliet; Letitia Smith; Leeanne J Mead; Finlay A Macrae; D James B St John; Graham G Giles; Melissa C Southey; Mark A Jenkins; Gary M Velan; John L Hopper
Journal:  Hum Mutat       Date:  2011-01-25       Impact factor: 4.878

3.  Possible maternal effect on severity of neurofibromatosis.

Authors:  M Miller; J G Hall
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

Review 4.  Neurofibromatosis 1.

Authors:  Timothy M Lynch; David H Gutmann
Journal:  Neurol Clin       Date:  2002-08       Impact factor: 3.806

5.  Discounting an adverse maternal effect on severity of neurofibromatosis.

Authors:  V M Riccardi; J S Wald
Journal:  Pediatrics       Date:  1987-03       Impact factor: 7.124

6.  von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

Authors:  R A Lewis; L P Gerson; K A Axelson; V M Riccardi; R P Whitford
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

7.  Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.

Authors:  Karlyne M Reilly; Robert G Tuskan; Emily Christy; Dagan A Loisel; Jeremy Ledger; Roderick T Bronson; C Dahlem Smith; Shirley Tsang; David J Munroe; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

8.  Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).

Authors:  J Szudek; H Joe; J M Friedman
Journal:  Genet Epidemiol       Date:  2002-08       Impact factor: 2.135

9.  Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.

Authors:  Robert G Tuskan; Shirley Tsang; Zhonghe Sun; Jessica Baer; Ester Rozenblum; Xiaolin Wu; David J Munroe; Karlyne M Reilly
Journal:  Epigenetics       Date:  2007-12-20       Impact factor: 4.528

10.  Parental origin of sequence variants associated with complex diseases.

Authors:  Augustine Kong; Valgerdur Steinthorsdottir; Gisli Masson; Gudmar Thorleifsson; Patrick Sulem; Soren Besenbacher; Aslaug Jonasdottir; Asgeir Sigurdsson; Kari Th Kristinsson; Adalbjorg Jonasdottir; Michael L Frigge; Arnaldur Gylfason; Pall I Olason; Sigurjon A Gudjonsson; Sverrir Sverrisson; Simon N Stacey; Bardur Sigurgeirsson; Kristrun R Benediktsdottir; Helgi Sigurdsson; Thorvaldur Jonsson; Rafn Benediktsson; Jon H Olafsson; Oskar Th Johannsson; Astradur B Hreidarsson; Gunnar Sigurdsson; Anne C Ferguson-Smith; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

View more
  2 in total

Review 1.  Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma.

Authors:  Cora A Ricker; Yuan Pan; David H Gutmann; Charles Keller
Journal:  Front Oncol       Date:  2016-12-20       Impact factor: 6.244

2.  Predictive Modeling for Clinical Features Associated With Neurofibromatosis Type 1.

Authors:  Stephanie M Morris; Aditi Gupta; Seunghwan Kim; Randi E Foraker; David H Gutmann; Philip R O Payne
Journal:  Neurol Clin Pract       Date:  2021-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.